MINISTRY OF HEALTH

THE CRIM INAL JUSTICE (INTERNATIONAL SI. No. 110 of 2000 CO-OPERATION) ACT, 2000

(No.42 of 2000)

THE CRIMINAL JUSTICE (INTERNATIONAL CO-OPERATION) REGULATIONS, 2000

The Minister, in exercise of the powers conferred by section 14(5) of the Criminal Justice (International Co-operation) Act, 2000, makes the following regulations —

Citation. 1. These Regulations may be cited as the Criminal Justice (Classes A, B and C Drugs) Regulations, 2000.

Drugs: 2. Class A, Class B and Class C drugs for the Classes A, purpose of subsection (4) of section 14 of the Criminal B and C. Justice (International Co—operation) Act 2000 are those respectively listed in Parts I, II and III of the Schedule to these Regulations.

SCHEDULE (Regulations 2)

PART I

CLASS A DRUGS

1. The following substances and products, namely-

(a)

ALE’ENTANIL

ALLYLPRODINE

ALPHACETYLMETH

ADOL REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-2-

ALPHAMEPRODINE

ALPHAMETHADOL

ALPRAPRODINE

ANILERIDINE

BENZETHIDINE

BENZYLMORPHINE (3—)

BETACETYLMETHADOL

BE TAME PROD IN E

BETAMETHADOL

BETAPRODINE

BEZITRAMIDE

BUFOTENINE

CANNABINOL

DERIVATIVES

CANNABINOL except where contained in or Cannabis resin

CARFENTANIL

CLONITAZENE

COCA LEAF

COCAINE

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-3-

DESOMORPHINE

DEXTROMORAMI DE

DIAMORPHINE

DIAMPROMI DE

DIETHYLTHIANBUTENE

DIFENOXIN (l- (3- cyano-3,3- diphenylpropyl)-4- phenylpiperidine-4- carboxylic acid)

DIHYDROCODEINO NE 0-

CARBOXYMETHYLO XIME

DIHYDRONORPHINE E

DIMENOX.ADOLE

DIMEPHEPTANOL

DIMETHYLTHIAF4BUTENE

DIOXAPHETYL

BUTYRATE

DIPHENOXYLATE

DIPIPAN0NE

DR0TEBAN0L (3,4-dimethoxy-17- methylmorphinan—6B, 14—diol) ECG0NINE and any derivative of ecgonine which is convertible to ecgonine or to cocaine REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-4-

ETHYLMETHYLTHIA

MBUTANE

ETICYCLIDINE

ETONITAZENE

ETORPHINE

ETOXERIDINE

FENTANYL

FURETHIDINE

HYDROCODONE

HYDROMORPHINOL

HYDROMORPHONE

HYCROXYPETHI DINE

ISOMETHADONE

KETOBEMI DONE

LEVOMETHORPHAN

LEVOMORAMI DE

LEVOPHENACY LMORPHAN

LEVORPHANOL

LOFENTANIL

LYSERGAMIDE

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-5-

LYSERGIDE and other N—alkyl derivatives of lysergamide

MESCALINE

METAZOCINE

METHADONE

METHADY L

ACETATE

METHYLAMINOREX

METHYLDESORPHINE

METHYLDIHYDROMORPHINE

METOPON

MORPHERIDINE (6-rnethyldihydromorphine)

MORPHINE

MORPHINE METHOBROMIDE, morphine n- oxide and other pentavalent nitrogen morphine derivatives

MYROPHINE

N, N-

DIETHYLTRYPTAMINE

N, N-

DIMETHYLTRYPTAMINE

N-HYDROXYTENANPHETANINE (N- hydroxy MDA)

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-6-

NICOMORPHINE (3, 6-dinicotinoylmorphine)

NORACYMETHADOL

NORLEVOR PHANO L

NOP.MET HA DONE

NORMORPHINE

NORPI PANONE

OPIUM whether raw, prepared or medicinal

OXYCODONE

OXYMORPHONE

PETHIDINE

PHENAD OXONE

PHENANPROMI DE

PHENAZOCINE

PHENCYCLIDINE

PHENOMORPH.AN

PHENOPERIDINE

PIMINODINE

PIRITRAMIDE

POPPY-STRAW and concentrate of poppy- straw

PROHEPTAZINE

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-7-

PROPERIDINE ) l-methyl-4-phenylpiperidine —4—carboxylic acid isopropyl ester) PSILOCIN

RACEMETHORPHAN

RACEMORAMIDE

RACEMORPHAN

ROLYCYCLIDINE

SUFENTANIL

TENOCYCLIDINE

THEBACON

THEBAINE

TILIDATE

TRIMEPERIDINE

4 -BROMO-2 , 5-DIMETHOXY-x-

METHYLPHENETHYLAMINE

4-CYANO-2-DIMETHYLAMINO-4 , 4

DIPHENYLBUTANE

4-CYANO- 1-METHYL-4-PHENYLPIPERDINE

2, 5-DIMETHOXY-x, 4- DIMETHYLPHENETHYLAMINE

2-METHYL- 3-MORPHOLINO-l , 1-

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-8-

DIPHENYLPROPANECARBOXYLIC ACID 1-METHYL-4-PHENYLPIPERIDINE—4- CARBOXYLIC ACID 4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER )norpethidine)

(b) any compound (not being a compound for the time being specified in sub-paragraph (a)) structurally derived from tryptamine or from a ring—hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub— paragraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, methylphenethylalflime, and N-Alkyl x- methylphenethylarfline, or an N-alkyl x— ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substrtuents, whether or not further substituted in the ring by one or more other univalent suhstitutents;

(d) any compound (not being a compound for the time being specified in sub—paragraph (a) ( structurally derived from by modification in any of the following ways, that is to say —

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle,

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups,

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups,

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-9-

(iv) by substitution in the aniline ring with alkyl, alkoxy alkylenedioxy, halogeno or haloalkyl groups,

(v) by substitution at the 4— position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(e) any compound (not being a compound for the time being specified in sub—paragraph (a) ) structurally derived from by modification in any of the following ways, that is to say —

(i) by replacement of the 1—methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted,

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propane bridge, whether or not further substituted,

(iii) by substitution in the 4—phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups,

(iv) by replacement of the 4— ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group,

(v) by formation of a N—oxide or of a quaternary base.

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 not being or .

3. Any ester or ether or a substance for the time being specified in paragraph 1 or 2 not being a substance for the time being specified in Part II of this Schedule.

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-10-

4. Any salt of a substance for the time being specified in any of paragraphs 1 to 3.

5. Any preparation or other product containing a substance or product for the time being specified in any of

paragraphs 1 to 4.

6. Any preparation designed for administration by injection specified in any of paragraphs 1 to 3 of Part II of

this Schedule.

PART II

CLASS B DRUGS

1. The following substances and products, namely

(a) AMPHETAMINE

CANNABIS AND CANNABIS RESIN

DIHYDROCODEINE

ETHYLMORPHINE (3-)

GLUTETHIMI DE

LEEETAMINE

MECLOQUALONE

METHAQUALONE

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-11-

METHYLAMPHETAMINE

METHYLPHENI DATE

METHYLPHENOBARBITONE

NICOCODINE

NICODICODINE (6-nicotinoyldihydrocodine)

NORCODEINE

PENTAZOCINE

PHENMETRAZINE

PHOLCODINE

PROP IRAN

(b) any 5,5 disubstituted barbituric acid.

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1.

3. Any salt of a substance for the time being specified in paragraph 1 or 2.

4. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3, not being a preparation falling within paragraph 6 of Part I.

PART III CLASS C DRUGS

1. The following substances and products, namely— ALPRAZOLAM BENZPHETANINE BROMAZEPAM

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-12-

BUPRENORPHINE

CAMAZEPAM

CATHINE

CATHINONE

CHLORDIAZEPOXIDE

CHLORPHENTERMINE

CLOBAZAM

CLONAZEPAM

CLORAZEPIC AcID

CLOTIAZEPAM

C LOXAZOLAM

DELORAZEPAM

DEXTROPROPOXYPHENE

DIAZEPAM

DIETHYLPROPION

ESTAZOLAM

ETHCHLORVYNOL

ETHINAMATE

ETHYL LOFLAZEPATE

F’ENCANFAMIN

FENETHYLLINE

FENPROPOREX

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-13-

FLUDIAZEPAM

FLUNITRAZEPAM

FLURAZEPAM

HALAZEPAM

HALOXAZOLAM

KETAZOLAM

LOPRAZOLAM

LORAZEPAM

LORMETAZ E PAM

MAZINDOL

MEDAZEPAM

MEFENOREX

MEPHENTERMINE

MEPROBAMATE

ME THYPRYLONE

MIDAZOLAM N-ETHYLAMPHETAMINE

NIMETAZEPAM

NITRAZEPAM

NORDIAZEPAM

OXAZEPAM

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT

-14-

OXAZOLAM

PEMOLINE

PHENDIMETRAZINE

PHENTERMINE

PINAZEPAM

PIPRADROL

PRAZEPAM

PROPYLHEXEDRINE

PYROVALERONE

TEMAZEPAM

TETRAZEPAM

TRIAZOLAM

2. Any stereojsomeric form of a substance for the time being specified in paragraph 1, not being phenylpropanolamine.

3. Any salt of a substance for the time being specified in paragraph 1 or 2.

4. Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3.

Made this 29th day of December, 2000.

Signed RONALD L. KNOWLES Minister responsible for Health

REPRINT FOR COMPLIANCE COMMISSION WEBSITE-NOT AN OFFICIAL DOCUMENT